SET pseudogene 14 (SETP14)

SET pseudogene 14 is a genomic DNA sequence sharing high sequence similarity with protein-coding SET genes, but it contains disabling mutations that prevent it from encoding a functional SET protein. Most pseudogenes like SETP14 are considered non-functional DNA remnants, originating via duplication or retrotransposition events[3][4][5]. While some pseudogenes may regulate gene expression through non-coding RNA mechanisms, there is no specific evidence that SETP14 performs any biological function or is relevant as a direct therapeutic or diagnostic target. Pseudogenes are defined as genomic sequences highly similar to protein-coding genes but rendered nonfunctional due to sequence disablements, such as frameshift mutations or premature stop codons[4][5]. Most pseudogenes do not produce functional proteins or serve as direct therapeutic targets, but some may act as regulatory noncoding RNAs (ceRNAs/miRNA sponges), primarily if expressed as RNA[3]. There is no published evidence that SETP14 has such functions. The functional SET gene (not SETP14) encodes a multitasking nuclear protein involved in apoptosis, transcription, and chromatin structure, but SETP14 is not a protein-coding gene[1]. Regarding the correctness of the target: SETP14 is a pseudogene with no evidence of protein-coding ability or direct druggability, and there is no literature support for its use as a biomarker, disease gene, or therapeutic target. Thus, it should not be considered a canonical molecular target (is_incorrect: true)[3][4][5].